-
B608166-25mgBMS pyrazole inhibitor 7f.
-
B608166-5mgBMS pyrazole inhibitor 7f.
-
-
-
B414226-100mgInformationBMS-1166 BMS-1166 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 interaction with an IC50 of 1.4 nM.TargetsPD-1/PD-L1 interaction 1.4 nMIn vitroBMS-1166 presents low toxicity towards tested cell lines and blocks the
-
B414226-25mgInformationBMS-1166 BMS-1166 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 interaction with an IC50 of 1.4 nM.TargetsPD-1/PD-L1 interaction 1.4 nMIn vitroBMS-1166 presents low toxicity towards tested cell lines and blocks the
-
B414226-2mgInformationBMS-1166 BMS-1166 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 interaction with an IC50 of 1.4 nM.TargetsPD-1/PD-L1 interaction 1.4 nMIn vitroBMS-1166 presents low toxicity towards tested cell lines and blocks the
-
B414226-5mgInformationBMS-1166 BMS-1166 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 interaction with an IC50 of 1.4 nM.TargetsPD-1/PD-L1 interaction 1.4 nMIn vitroBMS-1166 presents low toxicity towards tested cell lines and blocks the
-
-
-
B125576-100mgCdk inhibitor: potently inhibits cdk1 and cdk2.
-
B125576-10mgCdk inhibitor: potently inhibits cdk1 and cdk2.